February 27, 2025 - 13:00

NEW YORK, February 27, 2025—American Express Global Business Travel, a prominent player in the travel, expense, and meetings & events sector, has released its financial results for the fourth quarter and the entire year ending December 31, 2024. The company has showcased impressive growth, highlighting a robust recovery in the business travel sector.
For the fourth quarter, the company reported significant increases in revenue, driven by a surge in travel demand as businesses resumed in-person meetings and events. The overall performance for the year reflected a strong upward trend, with total revenues exceeding expectations. This momentum is expected to carry into 2025, as the company continues to innovate and enhance its service offerings to meet the evolving needs of corporate clients.
The leadership expressed optimism about the future, citing strategic investments and a focus on technology as key drivers of growth. With a positive outlook, American Express Global Business Travel is well-positioned to capitalize on the ongoing recovery in the global travel market.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...